DK131886D0 - PYRIDAZINONES, PROCEDURES FOR THEIR PREPARATION, AND PHARMACEUTICAL AGENTS CONTAINING THESE RELATIONSHIPS - Google Patents
PYRIDAZINONES, PROCEDURES FOR THEIR PREPARATION, AND PHARMACEUTICAL AGENTS CONTAINING THESE RELATIONSHIPSInfo
- Publication number
- DK131886D0 DK131886D0 DK131886A DK131886A DK131886D0 DK 131886 D0 DK131886 D0 DK 131886D0 DK 131886 A DK131886 A DK 131886A DK 131886 A DK131886 A DK 131886A DK 131886 D0 DK131886 D0 DK 131886D0
- Authority
- DK
- Denmark
- Prior art keywords
- group
- atom
- membered
- bonded via
- oxygen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
1. Pyridazinones of general formula I see diagramm : EP0196005,P30,F1 wherein X represents an oxygen or sulphur atom, R1 represents a saturated 5- to 7-membered alkyleneimino ring bonded via a nitrogen atom or a 5- to 7-membered saturated imino, N-alkylimino, N-phenylalkylimino, N-alkanoylimino or N-alkoxycarbonyliminoalkylene ring bonded via a carbon atom, whilst the above-mentioned rings may be substituted by one or two alkyl groups in the carbon structure and a methylene group in the 4-position of a 6- or 7-membered ring may be replaced by an oxygen or sulphur atom or by a sulphinyl, sulphonyl, imino, alkylimino, phenylalkylimino, alkoxycarbonylimino or alkanoylimino group, or R1 represents a saturated 5- to 7-membered alkyleneimino ring (optionally substituted by one or two alkyl groups) bonded via a nitrogen atom and in which a -CH2 CH2 - group is replaced by an -NH-CO group, the -CO- group in this -NH-CO- group being linked to the N-atom already present, or R1 represents a 5-membered heteroaromatic ring bonded via a nitrogen atom, which may additionally contain an oxygen or sulphur atom, one or two nitrogen atoms, or an oxygen or sulphur atom and a nitrogen atom and in which the heteroaromatic ring may be substituted by one or two alkyl groups, or in the case of a pyrazole, may alternatively be substituted by a hydroxy and an alkyl group, or R1 represents a 5- or 6-membered heteroaromatic ring bonded via a carbon atom, in which the heteroaromatic ring may contain an oxygen or sulphur atom, one, two or three nitrogen atoms, or an oxygen or sulphur atom and one or two nitrogen atoms, whilst the heteroaromatic rings may be substituted by one or two alkyl groups, by an amino or alkanoylamino group or, in the case of a pyridine, by one or two halogen atoms or by a halogen atom and an amino or morpholino group, and R2 represents a hydrogen atom or an alkyl group ; or X represents an imino group optionally substituted by an alkyl or phenylalkyl group, R1 represents a saturated 5- to 7-membered alkyleneimino ring bonded via a nitrogen atom or a 5- to 7-membered saturated imino, N-alkylimino, N-phenylalkylimino, N-alkanoylimino or N-alkoxycarbonyliminoalkylene ring bonded via a carbon atom, whilst the above-mentioned rings may be substituted by one or two alkyl groups in the carbon structure and a methylene group in the 4-position of a 6- or 7-membered ring may be replaced by an oxygen or sulphur atom or by a sulphinyl, sulphonyl, imino, alkylimino, phenylalkylimino, alkoxycarbonylimino or alkanoylimino group, or R1 represents a saturated 5- to 7-membered alkyleneimino ring (optionally substituted by one or two alkyl groups) bonded via a nitrogen atom and in which a -CH2 CH2 - groups is replaced by an -NH-CO group, the -CO- group in this -NH-CO- group being linked to the N-atom already present, and R2 represents a hydrogen atom or an alkyl group, whilst all the above-mentioned alkyl, alkanoyl or alkoxy groups may contain from 1 to 3 carbon atoms ; or X represents an imino group, R1 represents a 1-imidazolyl, 1-pyrazolyl, 3-methyl-1-pyrazolyl, 3-hydroxy-4-methyl-2-pyrazolyl or 1-[1.2.4]triazolyl group and R2 represents a methyl group in the 5-position ; or X represents an imino group, R1 represents a 2-chloro-6-morpholino-4-pyridyl group and R2 represents a hydrogen atom the optically active antipodes thereof, if R2 does not represent hydrogen, and the acid addition salts thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853511110 DE3511110A1 (en) | 1985-03-27 | 1985-03-27 | NEW PYRIDAZINONE, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK131886D0 true DK131886D0 (en) | 1986-03-21 |
| DK131886A DK131886A (en) | 1986-09-28 |
Family
ID=6266489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK131886A DK131886A (en) | 1985-03-27 | 1986-03-21 | PYRIDAZINONES, PROCEDURES FOR THEIR PREPARATION, AND PHARMACEUTICAL AGENTS CONTAINING THESE RELATIONSHIPS |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0196005B1 (en) |
| JP (1) | JPS61227582A (en) |
| KR (1) | KR860007253A (en) |
| AT (1) | ATE48841T1 (en) |
| AU (1) | AU5530386A (en) |
| CA (1) | CA1257588A (en) |
| DD (1) | DD248362A5 (en) |
| DE (2) | DE3511110A1 (en) |
| DK (1) | DK131886A (en) |
| ES (4) | ES8705882A1 (en) |
| FI (1) | FI861288A (en) |
| GR (1) | GR860801B (en) |
| HU (1) | HUT42085A (en) |
| IL (1) | IL78251A0 (en) |
| NO (1) | NO861266L (en) |
| NZ (1) | NZ215616A (en) |
| PT (1) | PT82272B (en) |
| ZA (1) | ZA862248B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3505609A1 (en) * | 1985-02-19 | 1986-08-21 | Merck Patent Gmbh, 6100 Darmstadt | BENZIMIDAZOLYL PYRIDAZINONE |
| US4725686A (en) * | 1985-11-22 | 1988-02-16 | William H. Rorer, Inc. | Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses |
| DE3611343A1 (en) * | 1986-04-04 | 1987-10-08 | Boehringer Mannheim Gmbh | HETEROCYCLICALLY SUBSTITUTED BENZIMIDAZOLES, METHOD FOR THEIR PRODUCTION, MEDICINAL PRODUCTS AND INTERMEDIATE PRODUCTS |
| DE3734083A1 (en) * | 1987-10-08 | 1989-04-20 | Heumann Pharma Gmbh & Co | BENZIMIDAZOLES, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
| DE3735207A1 (en) * | 1987-10-17 | 1989-04-27 | Basf Ag | MEDIUM BASED ON PHENYLPYRIDAZINONE DERIVATIVES FOR GROWTH ALLOY AND FET REDUCTION IN ANIMALS |
| ATE128135T1 (en) * | 1988-07-11 | 1995-10-15 | Akzo Nobel Nv | PYRIDAZINONE DERIVATIVES. |
| FR2643903A1 (en) * | 1989-03-03 | 1990-09-07 | Union Pharma Scient Appl | NOVEL BENZIMIDAZOLE DERIVATIVES, PROCESSES FOR PREPARING SAME, SYNTHESIS INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, IN PARTICULAR FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, AND DUODENIAL ULCERS |
| DE4237656A1 (en) * | 1992-06-13 | 1993-12-16 | Merck Patent Gmbh | benzimidazole derivatives |
| FR2806093B1 (en) * | 2000-03-08 | 2002-05-03 | Inst Francais Du Petrole | SELECTIVE HYDROGENATION PROCESS COMPRISING A PARTIAL SEPARATION OF HYDROGEN BY MEMBRANE UPSTREAM OF A REACTIVE COLUMN |
| CN101410385B (en) | 2006-03-28 | 2011-08-24 | 高点制药有限责任公司 | Benzothiazoles having histamine H3 receptor activity |
| WO2011138427A2 (en) | 2010-05-07 | 2011-11-10 | Boehringer Ingelheim International Gmbh | Pyridazinones as gpr119 agonists |
| WO2012149540A1 (en) | 2011-04-28 | 2012-11-01 | The Broad Institute Inc | Inhibitors of histone deacetylase |
| CA2880117C (en) | 2012-07-27 | 2021-04-06 | The Broad Institute, Inc. | Inhibitors of histone deacetylase |
| US9914717B2 (en) | 2012-12-20 | 2018-03-13 | The Broad Institute, Inc. | Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| WO2018086703A1 (en) | 2016-11-11 | 2018-05-17 | Bayer Pharma Aktiengesellschaft | Dihydropyridazinones substituted with phenylureas |
| CN112040951A (en) | 2018-01-31 | 2020-12-04 | 拜耳股份公司 | Antibody Drug Conjugates (ADC) with NAMPT inhibitors |
| WO2021013693A1 (en) | 2019-07-23 | 2021-01-28 | Bayer Pharma Aktiengesellschaft | Antibody drug conjugates (adcs) with nampt inhibitors |
| WO2023003468A1 (en) | 2021-07-23 | 2023-01-26 | Rijksuniversiteit Groningen | Novel inhibitors of histone deacetylase (hdac), and methods, compositions and uses related thereto. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8101067A1 (en) * | 1978-08-25 | 1980-12-01 | Thomae Gmbh Dr K | Benzimidazoles, their preparation and pharmaceutical compositions containing them. |
| DE3129447A1 (en) * | 1981-07-25 | 1983-02-10 | Dr. Karl Thomae Gmbh, 7950 Biberach | "NEW BENZTRIAZOLES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS" |
| DE3505609A1 (en) * | 1985-02-19 | 1986-08-21 | Merck Patent Gmbh, 6100 Darmstadt | BENZIMIDAZOLYL PYRIDAZINONE |
-
1985
- 1985-03-27 DE DE19853511110 patent/DE3511110A1/en not_active Withdrawn
-
1986
- 1986-03-18 DE DE8686103687T patent/DE3667664D1/en not_active Expired - Fee Related
- 1986-03-18 EP EP86103687A patent/EP0196005B1/en not_active Expired
- 1986-03-18 AT AT86103687T patent/ATE48841T1/en not_active IP Right Cessation
- 1986-03-21 DK DK131886A patent/DK131886A/en not_active Application Discontinuation
- 1986-03-25 IL IL78251A patent/IL78251A0/en unknown
- 1986-03-25 CA CA000505012A patent/CA1257588A/en not_active Expired
- 1986-03-25 DD DD86288285A patent/DD248362A5/en unknown
- 1986-03-26 JP JP61068255A patent/JPS61227582A/en active Pending
- 1986-03-26 ZA ZA862248A patent/ZA862248B/en unknown
- 1986-03-26 HU HU861275A patent/HUT42085A/en unknown
- 1986-03-26 NO NO861266A patent/NO861266L/en unknown
- 1986-03-26 GR GR860801A patent/GR860801B/en unknown
- 1986-03-26 ES ES553463A patent/ES8705882A1/en not_active Expired
- 1986-03-26 AU AU55303/86A patent/AU5530386A/en not_active Abandoned
- 1986-03-26 PT PT82272A patent/PT82272B/en unknown
- 1986-03-26 FI FI861288A patent/FI861288A/en not_active IP Right Cessation
- 1986-03-26 NZ NZ215616A patent/NZ215616A/en unknown
- 1986-03-26 KR KR1019860002262A patent/KR860007253A/en not_active Application Discontinuation
- 1986-11-21 ES ES557219A patent/ES8705884A1/en not_active Expired
- 1986-11-21 ES ES557218A patent/ES8705883A1/en not_active Expired
- 1986-11-21 ES ES557220A patent/ES8705885A1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3667664D1 (en) | 1990-01-25 |
| NO861266L (en) | 1986-09-29 |
| ZA862248B (en) | 1987-11-25 |
| EP0196005A1 (en) | 1986-10-01 |
| KR860007253A (en) | 1986-10-10 |
| ES553463A0 (en) | 1987-05-16 |
| ES557220A0 (en) | 1987-05-16 |
| ES557219A0 (en) | 1987-05-16 |
| CA1257588A (en) | 1989-07-18 |
| ES8705885A1 (en) | 1987-05-16 |
| DK131886A (en) | 1986-09-28 |
| EP0196005B1 (en) | 1989-12-20 |
| ES557218A0 (en) | 1987-05-16 |
| AU5530386A (en) | 1986-10-02 |
| IL78251A0 (en) | 1986-07-31 |
| PT82272B (en) | 1988-01-06 |
| GR860801B (en) | 1986-07-21 |
| FI861288A (en) | 1986-09-28 |
| HUT42085A (en) | 1987-06-29 |
| ATE48841T1 (en) | 1990-01-15 |
| ES8705884A1 (en) | 1987-05-16 |
| ES8705882A1 (en) | 1987-05-16 |
| DD248362A5 (en) | 1987-08-05 |
| FI861288A0 (en) | 1986-03-26 |
| PT82272A (en) | 1986-04-01 |
| DE3511110A1 (en) | 1986-10-02 |
| NZ215616A (en) | 1990-01-29 |
| ES8705883A1 (en) | 1987-05-16 |
| JPS61227582A (en) | 1986-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK131886A (en) | PYRIDAZINONES, PROCEDURES FOR THEIR PREPARATION, AND PHARMACEUTICAL AGENTS CONTAINING THESE RELATIONSHIPS | |
| NZ334710A (en) | Heterocycle derivatives which inhibit factor Xa attributed to strong anticoagulant and antithrombotic effect of compounds | |
| GEP19970817B (en) | Oxadiazole-alkyl-purine derivatives | |
| FI833907A0 (en) | NAFTALEN-ANTI-PSORIATIC SUBSTANSER | |
| NO170215C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLD DERIVATIVES | |
| KR890006629A (en) | 1-((5-((4-substituted-1-piperazinyl) methyl) -pyrrole-2yl or furan-2-yl) methyl-2-piperidinone useful for treating schizophrenia | |
| ATE34978T1 (en) | IMIDAZOLINONE DERIVATIVES AS HISTAMINE H2 ANTAGONISTS. | |
| ES8305757A1 (en) | Heterocyclic nitriles, their preparation and their use in the preparation of medicaments. | |
| HU913892D0 (en) | Method for producing new alkyl-amino-alkyl-amine and -ether derivatives and pharmaceutical preparatives containing said compounds | |
| DE69018996T2 (en) | IMIDAZOLE DERIVATIVES AND THEIR USE AS ACYL COENYZM-A INHIBITORS. | |
| DK141187D0 (en) | 1- (3- (2-DIALKYLAMINOETHOXY) -2-THIENYL) -3-PHENYL-1-PROPANONES AND ACID ADDITION SALTS THEREOF, PROCEDURE OF SUCH COMPOUNDS, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE | |
| DK119886A (en) | UNKNOWN CARBACYCLINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS A MEDICINE | |
| NZ335975A (en) | Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases | |
| TR199903022T2 (en) | 5-Naphthalin-1-yl-1, 3-dioxane derivatives, preparations and therapeutic applications. | |
| TW351717B (en) | Pyenyl-substituted cyclic ketoenols | |
| GR910300109T1 (en) | 5-(amino)-triazolylcarbothioamide derivatives, process for their preparation and medicines containing them, as well as use of the former | |
| ES439014A1 (en) | Benzisoxazole derivatives | |
| MY102895A (en) | Benzimidazoles, benzoxazoles, benzothiazoles and their production, formulation and use gastric acid secretion inhibitors. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |